Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3010% above fair value
$134.93−2.95 (-2.14%)
Close on Nov 18, 2026Market cap $13.31BP/E 22.0Yield 0.53%
Encompass Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Encompass Health's operating income for the twelve months ending Dec 31, 2022 was $539.50M, down 3.6% year over year. For fiscal 2022 it was $539.50M, down 3.6% from the year before. The highest annual figure on record is $612.10M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $539.50M | -3.6% |
| FY2021 | Dec 31, 2021 | $559.60M | -0.8% |
| FY2020 | Dec 31, 2020 | $563.90M | -7.9% |
| FY2019 | Dec 31, 2019 | $612.10M | +10.2% |
| FY2018 | Dec 31, 2018 | $555.20M | -4.0% |
| FY2017 | Dec 31, 2017 | $578.30M | -1.7% |
| FY2016 | Dec 31, 2016 | $588.10M | +21.1% |
| FY2015 | Dec 31, 2015 | $485.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $151.90M | +18.3% |
| Q3 FY2022 | Sep 30, 2022 | $127.50M | -9.8% |
| Q2 FY2022 | Jun 30, 2022 | $128.60M | -12.4% |
| Q1 FY2022 | Mar 31, 2022 | $131.50M | -8.0% |
| Q4 FY2021 | Dec 31, 2021 | $128.40M | -23.7% |
| Q3 FY2021 | Sep 30, 2021 | $141.40M | -6.4% |
| Q2 FY2021 | Jun 30, 2021 | $146.80M | +72.3% |
| Q1 FY2021 | Mar 31, 2021 | $143.00M | -10.2% |
| Q4 FY2020 | Dec 31, 2020 | $168.30M | +19.2% |
| Q3 FY2020 | Sep 30, 2020 | $151.10M | -0.1% |
| Q2 FY2020 | Jun 30, 2020 | $85.20M | -44.2% |
| Q1 FY2020 | Mar 31, 2020 | $159.30M | -4.7% |
| Q4 FY2019 | Dec 31, 2019 | $141.20M | +51.2% |
| Q3 FY2019 | Sep 30, 2019 | $151.20M | -2.1% |
| Q2 FY2019 | Jun 30, 2019 | $152.60M | -3.0% |
| Q1 FY2019 | Mar 31, 2019 | $167.10M | +11.4% |
| Q4 FY2018 | Dec 31, 2018 | $93.40M | -35.5% |
| Q3 FY2018 | Sep 30, 2018 | $154.50M | +6.4% |
| Q2 FY2018 | Jun 30, 2018 | $157.30M | +11.3% |
| Q1 FY2018 | Mar 31, 2018 | $150.00M | +2.0% |
| Q4 FY2017 | Dec 31, 2017 | $144.70M | -0.5% |
| Q3 FY2017 | Sep 30, 2017 | $145.20M | -2.0% |
| Q2 FY2017 | Jun 30, 2017 | $141.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $147.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $145.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $148.20M | – |
See a number that looks wrong?